Optical genome mapping identified a recurrent t(14;16) chromosomal translocation involving the BCL11B enhancer in two patients diagnosed with rare T/myeloid mixed-phenotype acute leukemia. The report points to how high-resolution structural variant mapping can clarify genetic drivers in uncommon, difficult-to-classify hematologic malignancies. In mixed-phenotype acute leukemia, determining underlying rearrangements can be critical for risk stratification and potentially for therapeutic decision-making. The t(14;16) finding suggests a consistent genetic pattern rather than case-specific variation. For centers adopting optical genome mapping, this provides a concrete example of how the technology can detect clinically relevant translocations in small patient subsets.